StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.40+0.34 (+11.11%)

Close on Nov 19, 2026Market cap $69.81KP/E –Yield –

Addex Therapeutics cash

Cash and short-term investments held at the end of each period.

Addex Therapeutics's cash was CHF 767.33K at Jun 30, 2026. For fiscal 2025 it was CHF 1.64M, down 51.0% from the year before. The highest annual figure on record is CHF 31.54M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 1.64M-51.0%
FY2024Dec 31, 2024CHF 3.34M-13.5%
FY2023Dec 31, 2023CHF 3.87M-44.4%
FY2022Dec 31, 2022CHF 6.96M-66.0%
FY2021Dec 31, 2021CHF 20.48M+9.6%
FY2020Dec 31, 2020CHF 18.70M-40.7%
FY2019Dec 31, 2019CHF 31.54M0.0%
FY2018Dec 31, 2018CHF 31.54M+1122.7%
FY2017Dec 31, 2017CHF 2.58M+82.9%
FY2016Dec 31, 2016CHF 1.41M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 767.33K-79.7%
Q4 FY2025Dec 31, 2025CHF 1.64M-57.6%
Q2 FY2025Jun 30, 2025CHF 2.30M-67.9%
Q4 FY2024Dec 31, 2024CHF 3.34M-52.0%
Q2 FY2024Jun 30, 2024CHF 3.79M-57.0%
Q4 FY2023Dec 31, 2023CHF 3.87M-81.1%
Q2 FY2023Jun 30, 2023CHF 7.17M-60.4%
Q4 FY2022Dec 31, 2022CHF 6.96M-62.8%
Q2 FY2022Jun 30, 2022CHF 8.81M-72.1%
Q4 FY2021Dec 31, 2021CHF 20.48M-35.0%
Q2 FY2021Jun 30, 2021CHF 18.11M+602.1%
Q4 FY2020Dec 31, 2020CHF 18.70M+1225.8%
Q4 FY2019Dec 31, 2019CHF 31.54M–
Q4 FY2018Dec 31, 2018CHF 31.54M–
Q4 FY2017Dec 31, 2017CHF 2.58M–
Q4 FY2016Dec 31, 2016CHF 1.41M–

More Addex Therapeutics figures

See a number that looks wrong?